Is Merck (MRK) a Buy as Wall Street Analysts Look Optimistic?

The article is a general discussion about whether sell-side analyst rating changes meaningfully affect stock performance, rather than a company-specific event. It frames analyst recommendations as a market catalyst but does not cite any stock, earnings figure, or rating change. The piece is informational and should have limited direct market impact.

Analysis

The article is a general discussion about whether sell-side analyst rating changes meaningfully affect stock performance, rather than a company-specific event. It frames analyst recommendations as a market catalyst but does not cite any stock, earnings figure, or rating change. The piece is informational and should have limited direct market impact.